Alligator Bioscience AB (publ) reported earnings results for the second quarter and six months ended June 30, 2024. For the second quarter, the company reported sales was SEK 7.58 million compared to SEK 17.36 million a year ago. Revenue was SEK 7.9 million compared to SEK 18.67 million a year ago. Net loss was SEK 49.21 million compared to SEK 63.71 million a year ago. Basic loss per share from continuing operations was SEK 0.07 compared to SEK 0.19 a year ago. Diluted loss per share from continuing operations was SEK 0.07 compared to SEK 0.19 a year ago.
For the six months, sales was SEK 14.55 million compared to SEK 26.96 million a year ago. Revenue was SEK 15.38 million compared to SEK 29.09 million a year ago. Net loss was SEK 111.96 million compared to SEK 126.26 million a year ago. Basic loss per share from continuing operations was SEK 0.16 compared to SEK 0.46 a year ago. Diluted loss per share from continuing operations was SEK 0.16 compared to SEK 0.46 a year ago.